CSIMarket
 
Conmed Corporation  (CNMD)
Other Ticker:  
 
 
Price: $72.6100 $-0.03 -0.041%
Day's High: $73.08 Week Perf: -6.26 %
Day's Low: $ 71.55 30 Day Perf: -4.72 %
Volume (M): 342 52 Wk High: $ 138.47
Volume (M$): $ 24,818 52 Wk Avg: $105.57
Open: $73.04 52 Wk Low: $70.57



 Market Capitalization (Millions $) 2,294
 Shares Outstanding (Millions) 32
 Employees 3,000
 Revenues (TTM) (Millions $) 1,245
 Net Income (TTM) (Millions $) 64
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 19

Conmed Corporation
Conmed Corporation is a global medical technology company that specializes in the development, manufacturing, and sales of surgical devices and equipment. The company's products are used in surgical procedures across several medical specialties, including orthopedics, gastroenterology, gynecology, respiratory therapy, and cardiology.

Conmed Corporation was founded in 1970 in Utica, New York. The company has since expanded its operations globally with offices throughout North America, Europe, and Asia. Its headquarters are in Utica, New York.

The company's product offerings include a vast range of surgical instruments, electrosurgical systems, patient monitoring equipment, endoscopy equipment, and imaging systems. They aim to develop innovative solutions to address the needs of healthcare professionals around the world.

Conmed is also known for its advanced energy products that are used in surgical procedures. The company's energy products range from generators and surgical instruments to accessories like medical tapes, electrodes, and connectors. Conmed's EDGE Technology is one of the latest advancements in surgical technology, utilizing both radiofrequency and ultrasound energy to deliver precise and efficient results.

In recent years, Conmed has acquired several companies, including SurgiQuest, Buffalo Filter, and Westmed. These acquisitions have allowed the company to expand its product offerings and solidify its position as a major player in the medical technology industry.

In addition to its core product offerings, Conmed also provides educational resources to healthcare professionals through its Clinical Education Department. The department conducts training sessions, seminars, and workshops to help healthcare professionals stay up-to-date on the latest surgical techniques and innovations.

Conmed has received several awards and recognitions for its innovative products, including the Medical Design Excellence Award, the Clinician's Choice Award, and the Frost & Sullivan Product Innovation Award.

The company is committed to sustainability and reducing its environmental impact. Conmed has implemented various initiatives to reduce waste, energy consumption, and greenhouse gas emissions. They also have a program in place for recycling medical devices and instruments.

Overall, Conmed Corporation is a leading medical technology company that continues to drive innovation in the surgical industry. With a wide range of products and a commitment to sustainability, the company is well-positioned for continued growth and success.


   Company Address: 11311 Concept Boulevard Largo, 33773 FL
   Company Phone Number: 392-6464   Stock Exchange / Ticker: NYSE CNMD
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Conmed Corporation

Conmed Corporation Achieves Remarkable Financial Milestones in October-December 2023

As a financial journalist covering the latest developments in the market, it is my duty to provide a comprehensive analysis of the recent financial results announced by Conmed Corporation (NYSE: CNMD). Despite the company's positive performance in terms of income growth, EPS elevation, and revenue jumps, it is crucial to shed light on the recent decline in Conmed Corporation's shares.
In the financial interval closing December 31, 2023, Conmed Corporation reported a substantial increase in income, with a growth of 17.88% from $0.87 to $1.02 per share compared to the previous year. Additionally, the EPS saw a remarkable leap of 104.85% from $0.50 per share in the prior reporting season. These figures undoubtedly indicate the growing profitability of the company and its ability to generate higher returns for its shareholders.

Dividend

CONMED Corporation Announces Quarterly Cash Dividend, Reflecting Strong Financial Performance

Published Tue, Feb 27 2024 9:05 PM UTC



In a recent press release, CONMED Corporation (NYSE: CNMD), a leading medical technology company, has declared a quarterly cash dividend of $0.20 per share. This announcement comes as a testament to the company's robust financial performance and commitment to rewarding its shareholders. With a wide range of surgical devices and equipment for minimally invasive proc...

Dividend

CONMED Corporation: Empowering Shareholders through Dividend Growth and Technological Advancements

Published Tue, Dec 5 2023 9:05 PM UTC


In a recent press release, CONMED Corporation (NYSE: CNMD) announced the declaration of a quarterly cash dividend of $0.20 per share on December 4, 2023. The dividend is scheduled for payment on January 5, 2024, to shareholders of record as of December 18, 2023. This move underscores CONMED's commitment to rewarding its shareholders while highlighting the company's stab...

Conmed Corporation

Conmed Corporation Shines with Compelling Revenue Growth Despite Dip in Earnings


By:

As we delve into Conmed Corporation's latest financial results for the July to September 2023 quarter, a clear trend emerges - the medical equipment and supplies company has experienced a decline in earnings per share (EPS) despite substantial revenue growth. While the dip in EPS may raise concerns, it is crucial to examine the various factors driving this performance and understand the company's strategic focus moving forward.
During the third quarter of 2023, Conmed Corporation witnessed a significant 10.72% surge in revenue, reaching an impressive $304.58 million compared to the corresponding quarter a year ago. However, the company's income per share witnessed a sharp dip of -66.22%, amounting to $0.50 per share for the same period. This decline is concerning, but it is worth noting that the company's income per share did see a positive increase of 16.28% from the preceding quarter, where it stood at $0.43 per share.

Conmed Corporation

Conmed Corporation Triumphs with Remarkable 616.67% Earnings Growth and 14.6% Revenue Boost in Q2 2023 - Returns to Profitability!

Conmed Corporation, a company trading on the New York Stock Exchange (NYSE), has experienced a noticeable decline in its stock price over the past 5 trading days. The stock dropped by -8.42%, bringing its year-to-date performance to an impressive 36.14%. Currently, the stock is trading 21.1% above its 52-week average on the NYSE.
Despite the recent decline in stock price, Conmed Corporation's financial performance in the most recent fiscal period appears to be positive. The company reported a net income of $0.43 per share, a significant improvement from a loss of $-5.65 per share in the previous year. This represents a remarkable increase of 616.67%.
Furthermore, Conmed Corporation's revenue also experienced growth, with a 14.597% increase to $317.65 million compared to $277.19 million in the same period the previous year. Sequentially, the revenue showed a 7.508% increase from $295.47 million. These numbers indicate the company's ability to attract partners and achieve stability and advantage in the market.






 

Conmed's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Conmed does not provide revenue guidance.

Earnings Outlook
Conmed Corporation does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com